News

We invite you to visit our news section for updates on research articles related to maternal and neonatal mortality and technology, MANDATE in the news, and information on new technology briefs.

NOV
7

MANDATE participates in Saving Lives at Birth / Grand Challenges Meeting in New Delhi, India

The United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and The World Bank have joined together to launch Saving Lives at Birth: A Grand Challenge for Development, to find the tools and approaches to help the mothers and newborns during their most vulnerable hours. Grand Challenges is currently hosting a conference in New Delhi until November 7th 2011, bringing together technical experts, public health professionals and technology developers around the world to discuss the state of maternal and child health and develop solutions to reduce the current burden of morbidity and mortality around pregnancy and birth.

Check out the Saving Lives at Birth: A Grand Challenge for Development blog to hear more about the conference.

(To view more, click on this link).
OCT
25

Zambia: Challenges of Maternal Health Care

Despite the numerous efforts being made by the Government and its cooperating partners, access to quality maternal and newborns health care has continued to remain a major challenge for most Sub-Sahara African countries.

(To view more, click on this link).
OCT
24

To Improve 7 billion Lives, One Hand Washes the Other

As we prepare for the world population to reach 7 billion at the end of this month, smart development programs understand the importance of leveraging interactions with hard-to-reach people to solve more than one problem at a time. Hand washing is one of those opportunities.

(To view more, click on this link).
OCT
18

Study Finds Clues to Sneak Protein Linked to Pre-Eclampsia

Dr. Harvey Kliman, a reproductive sciences researcher at Yale School of Medicine has found a potential link between Placental Protein 13 (PP13) and pre-eclampsia. Based on placental specimens from normal pregnancies that were terminated before the fourteenth week of gestation, researchers tested the specimens and found large concentrations of protein PP13. While this does not necessarily translate into a treatment for pre-eclampsia, a new diagnostic test could be developed based on PP13 levels to identify women at risk for pre-eclampsia early in gestation.

(To view more, click on this link).
OCT
18

Pregnant Women's Gains From Extra Calcium May Be Limited

According to a recent meta-analysis of 21 randomized controlled trials to determine benefit of calcium supplementation on pregnancy and birth outcomes, researchers have found that supplementation did not lower the risk of preterm birth or low birth weight. Buppasiri P et al. however did find that calcium supplementation was protective against pre-eclampsia.

(To view more, click on this link).